Neural tube defect

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3388
Who is this for?
Show terms as
6Active trials36Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Neural tube defects (NTDs) are a group of congenital malformations that occur when the neural tube — the embryonic structure that develops into the brain and spinal cord — fails to close completely during the first few weeks of pregnancy (typically between days 21 and 28 after conception). This group of conditions includes several well-known subtypes: anencephaly (absence of a major portion of the brain and skull), spina bifida (incomplete closure of the spinal column), and encephalocele (protrusion of brain tissue through an opening in the skull). The severity of NTDs ranges widely, from conditions incompatible with life (such as anencephaly) to milder forms like spina bifida occulta, which may be asymptomatic. The clinical features depend on the type and location of the defect. Spina bifida, the most common survivable form, can cause varying degrees of paralysis of the lower limbs, bladder and bowel dysfunction, hydrocephalus (accumulation of cerebrospinal fluid in the brain), orthopedic abnormalities, and learning difficulties. Anencephaly is uniformly fatal, with most affected infants being stillborn or dying shortly after birth. Encephalocele can cause intellectual disability, vision problems, and motor deficits depending on the amount of brain tissue involved. Neural tube defects have a multifactorial etiology involving both genetic susceptibility and environmental factors. Maternal folate (folic acid) deficiency is the best-established modifiable risk factor, and periconceptional folic acid supplementation has been shown to reduce the risk of NTDs by up to 70%. Other risk factors include maternal diabetes, obesity, certain anticonvulsant medications (particularly valproic acid), and genetic variants in folate metabolism pathways (such as MTHFR). Treatment depends on the specific defect: spina bifida may be treated with surgical closure of the defect either prenatally (fetal surgery) or shortly after birth, along with management of hydrocephalus through ventriculoperitoneal shunting. Lifelong multidisciplinary care involving neurosurgery, urology, orthopedics, and rehabilitation is often required for individuals with spina bifida. Prevention through folic acid fortification of food and supplementation remains the cornerstone of public health strategy.

Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Nov 2025Effectiveness of Electrical Pudendal Nerve Stimulation for Neurogenic Lower Urinary Tract Dysfunction in Pediatric Tethered Cord Syndrome Post-Surgery

Shanghai Institute of Acupuncture, Moxibustion and Meridian — NA

TrialNOT YET RECRUITING
Jul 2025Fetoscopic Robotic Open Spina Bifida Treatment

Mount Sinai Hospital, Canada — NA

TrialNOT YET RECRUITING
May 2025Efficacy Of Pulsed Electromagnetic Field Therapy On Neurogenic Bladder in Children With Myelomeningocele

South Valley University — NA

TrialACTIVE NOT RECRUITING
Feb 2024A Randomized Controlled Trial for Surgical Treatment of Recurrent Adult Tethered Cord Syndrome

Xuanwu Hospital, Beijing — NA

TrialNOT YET RECRUITING
Jan 2024Evaluation of the Transitional and Lifelong Care Program

Western University, Canada

TrialRECRUITING
Apr 2023Fetoscopic Neural Tube Defect Repair

Oregon Health and Science University

TrialRECRUITING
Jan 2023Brain Health With Inner Engineering Meditation

Beth Israel Deaconess Medical Center — NA

TrialRECRUITING
Nov 2022Safety and Efficacy of Devices Used in Fetoscopic Neural Tube Defect Repair Cases

Michael A Belfort — NA

TrialRECRUITING
Dec 2018Patch vs. No Patch Fetoscopic Meningomyelocele Repair Study

Baylor College of Medicine — PHASE1

TrialACTIVE NOT RECRUITING
Nov 2018Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele

USFetus — NA

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Neural tube defect.

6 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

6 recruitingView all trials with filters →
Phase 11 trial
Patch vs. No Patch Fetoscopic Meningomyelocele Repair Study
Phase 1
Active
PI: Michael A. Belfort, M.D., Ph.D. (Baylor College of Medicine) · Sites: Stanford, California; Houston, Texas · Age: 1864 yrs
N/A4 trials
Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele
N/A
Actively Recruiting
PI: Ruben Quintero, MD (Wellington Regional Medical Center) · Sites: Los Angeles, California; Wellington, Florida · Age: 1899 yrs
Fetoscopic Repair of Isolated Fetal Spina Bifida
N/A
Active
PI: Jena Miller, MD (Johns Hopkins University) · Sites: Baltimore, Maryland · Age: 1850 yrs
Safety and Efficacy of Devices Used in Fetoscopic Neural Tube Defect Repair Cases
N/A
Actively Recruiting
PI: Michael A Belfort, MD (Baylor College of Medicine and Texas Children's Ho) · Sites: Houston, Texas · Age: 1899 yrs
In-Utero Endoscopic Correction of Spina Bifida
N/A
Actively Recruiting
PI: Ruben Quintero, MD (US Fetus) · Sites: Los Angeles, California; Wellington, Florida · Age: 1852 yrs
Other1 trial
Fetoscopic Neural Tube Defect Repair
Actively Recruiting
PI: Raphael Sun, MD (Oregon Health and Science University) · Sites: Portland, Oregon · Age: 1899 yrs

Specialists

Showing 25 of 36View all specialists →
MP
Michael Belfort, MD, PhD
HOUSTON, TX
Specialist
PI on 3 active trials
RM
Ruben Quintero, MD
MIAMI, FL
Specialist
PI on 3 active trials
MP
Michael A. Belfort, M.D., Ph.D.
HOUSTON, TX
Specialist
PI on 1 active trial
RM
Ramesha Papanna, MD, MPH
HOUSTON, TX
Specialist
PI on 2 active trials
UD
Urielle Desalbres
Specialist
PI on 21 active trials1 Neural tube defect publication
RM
Reynaldo Martorell, PHD, MPH
Specialist
PI on 1 active trial
RM
Raphael Sun, MD
PORTLAND, OR
Specialist
PI on 2 active trials
RM
Robert S Adelstein, M.D.
Specialist
PI on 2 active trials
MP
Michel Zerah, MD, PhD
FAIRFAX, VA
Specialist
PI on 2 active trials
RP
Rodrigo Ruano, M.D., Ph.D.
MIAMI, FL
Specialist
PI on 2 active trials
AC
Andrew Chon
Specialist
PI on 1 active trial9 Neural tube defect publications
CD
Christelle Destinval
Specialist
PI on 2 active trials1 Neural tube defect publication
YP
Yves Ville, MD, PhD
Specialist
PI on 2 active trials
SK
Steven Knafo
Specialist
PI on 2 active trials
DP
David D Limbrick, MD, PhD
SAINT LOUIS, MO
Specialist
PI on 1 active trial
TP
Thomas C Bulea, Ph.D.
Bethesda, Maryland
Specialist

Rare Disease Specialist

PI on 3 active trials
MC
Magdalin Cheong
Specialist
PI on 1 active trial2 Neural tube defect publications
SM
Suzanne L Groah, MD, MSPH
WASHINGTON, DC
Specialist
PI on 1 active trial
BM
Burak C. Balık, MD
Specialist
PI on 1 active trial
RM
Richard Adams, MD
Specialist
PI on 1 active trial
RM
Recep Karakaşoğlu, MD
Specialist
PI on 1 active trial
LP
Laurent Siproudhis, Md, PhD
Specialist
PI on 1 active trial
AP
Allison Ashley-Koch, PhD
Specialist
PI on 2 active trials
KM
kristina m casteels, MD
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Neural tube defect.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Neural tube defectForum →

No community posts yet. Be the first to share your experience with Neural tube defect.

Start the conversation →

Latest news about Neural tube defect

Disease timeline:

New recruiting trial: Transcutaneous Spinal Stimulation for Children and Youth With Spina Bifida

A new clinical trial is recruiting patients for Neural tube defect

New recruiting trial: Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele

A new clinical trial is recruiting patients for Neural tube defect

New recruiting trial: In Utero Surgery for Fetal Myelomeningocele: Decision-making Mechanisms and Psychological Impact of Prenatal Therapy

A new clinical trial is recruiting patients for Neural tube defect

New recruiting trial: Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial

A new clinical trial is recruiting patients for Neural tube defect

New recruiting trial: In-Utero Endoscopic Correction of Spina Bifida

A new clinical trial is recruiting patients for Neural tube defect

New recruiting trial: Impact of Standing Programs in Children With Spina Bifida: A Single Subject Design

A new clinical trial is recruiting patients for Neural tube defect

New recruiting trial: Brain Health With Inner Engineering Meditation

A new clinical trial is recruiting patients for Neural tube defect

New recruiting trial: Evaluation of muLtimodal and Non-invasive SPINa Bifida Neurovessels During Prospective Follow-up

A new clinical trial is recruiting patients for Neural tube defect

New recruiting trial: Fetoscopic Neural Tube Defect Repair

A new clinical trial is recruiting patients for Neural tube defect

New recruiting trial: QUALAS Validation in Dutch

A new clinical trial is recruiting patients for Neural tube defect

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Neural tube defect

What is Neural tube defect?

Neural tube defects (NTDs) are a group of congenital malformations that occur when the neural tube — the embryonic structure that develops into the brain and spinal cord — fails to close completely during the first few weeks of pregnancy (typically between days 21 and 28 after conception). This group of conditions includes several well-known subtypes: anencephaly (absence of a major portion of the brain and skull), spina bifida (incomplete closure of the spinal column), and encephalocele (protrusion of brain tissue through an opening in the skull). The severity of NTDs ranges widely, from cond

How is Neural tube defect inherited?

Neural tube defect follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Neural tube defect typically begin?

Typical onset of Neural tube defect is neonatal. Age of onset can vary across affected individuals.

Are there clinical trials for Neural tube defect?

Yes — 6 recruiting clinical trials are currently listed for Neural tube defect on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Neural tube defect?

25 specialists and care centers treating Neural tube defect are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.